You are here: Industry Insights > Market News > South Africa asks SII to take back one million doses of COVID-19 vaccine: Reports

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

Hot Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

South Africa asks SII to take back one million doses of COVID-19 vaccine: Reports

expresspharmaFebruary 18, 2021

Tag: South Africa , COVID-19 Vaccine , 501Y.V2 , SII

Favorites

South Africa has asked the Serum Institute of India to take back one million doses of COVID-19 vaccine that the company had sent in early February, as per a report in The Economic Times.

The company did not immediately respond to a Reuters request for comment.

South Africa’s health minister had informed last week that the government could sell AstraZeneca’s vaccine after the country halted its rollout following a small clinical trial that showed it offered minimal protection against mild to moderate illness from the 501Y.V2 coronavirus variant.

Previous:Glenmark launches SUTIB (Sunitinib) capsules in India to treat kidney cancer

Next:Research reveals Pfizer-BioNTech COVID-19 vaccine elicits strong immune response with single dose

InnoCare Sets up Specific Environment Management Target in its Fifth ESG Report

PharmaSourcesApril 28, 2024

InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases.

Touchlight Awarded Grant Extension to Further Develop DNA-Enabled Biobatteries with U.S. Office for Naval Research and UK Defence Science & Technology Laboratory

Biotech NewswireApril 26, 2024

Study Results of Orelabrutinib in Patients with ITP Published by the American Journal of Hematology

PharmaSourcesApril 18, 2024

South Africa asks SII to take back one million doses of COVID-19 vaccine: Reports | Pharmasources.com

Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology

PharmaSourcesApril 17, 2024

Company is targeting pancreatic cancer pain with advanced nerve detection and treatment technology

South Africa asks SII to take back one million doses of COVID-19 vaccine: Reports

Related News

InnoCare Sets up Specific Environment Management Target in its Fifth ESG Report

Touchlight Awarded Grant Extension to Further Develop DNA-Enabled Biobatteries with U.S. Office for Naval Research and UK Defence Science & Technology Laboratory

Study Results of Orelabrutinib in Patients with ITP Published by the American Journal of Hematology

Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology

You may like